POLR3K and systemic sclerosis: In one of the subjects, autoantibodies against two components of RNAP III, POLR3A and POLR3K, rose 13- and 122-fold, respectively from a seronegative status only -1.1 years before diagnosis suggesting a rapid evolution of the autoantibody response before SSc/SRC manifests (Fig 4F).